NFKB1 and neoplasm: Indeed, we reported that the NF-κB inhibitor, dimethylaminoparthenolide (DMAPT), restored skeletal muscle functions including grip strength and motion performance in mammary tumor-bearing mice, accompanied by amelioration of few of the tumor-associated skeletal muscle molecular defects [13].